Biotech Salaries Are Rising | Ep. 676

But the Picture Isn’t All Rosy

Hello Avatar! Welcome back for another week of biotech analysis. Today is Sunday, which means this is our Building Biotech newsletter that is focused on discussing biopharma strategy topics. Today we will unpack what’s driving a surprising 9% increase in average salaries, while somehow equity and bonus components of pay packages are falling. We will look at how benefits and flexibility are shaping job decisions, and the persistent gaps that still exist across gender and race. Whether you're hiring, job hunting, or just benchmarking your worth, this breakdown will help you understand how compensation is shifting in today’s leaner, more selective biopharma market.

We are now publishing 7x per week according to the following cadence:

• Mondays: Stocks

• Tuesdays: Biotech

• Wednesdays: Podcast

• Thursdays: Markets

• Fridays: News

• Saturdays: Podcast

• Sundays: Strategy

We are also publishing unique content on X - be sure to follow up if you are not already @BowTiedBiotech. And to check-out the archive of our work on X you can find it on our website at: BowtiedBiotech.subtack.com/x-articles.

SUBSCRIBE TO PODCAST HERE:

Please help spread the work by subscribing and hitting the share button if you are enjoying our bi-weekly newsletters!

Enough shilling for the day, lots to cover this week, let's get started!

Base Pay Is Up, But There’s a Catch